FANCM Protein

FANCM Protein — Fanconi Anemia Group M

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">FANCM Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Fanconi anemia group M protein</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>FA-M, MHF1, FAAP24-associated</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>250 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>2148 amino acids</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q8IWA5">Q8IWA5</a></td></tr>
<tr><td><strong>Cellular Location</strong></td><td>Nucleus (chromatin), cytoplasm</td></tr>
<tr><td><strong>Protein Class</strong></td><td>DNA translocase, SF2 helicase</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

FANCM Protein — Fanconi Anemia Group M

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">FANCM Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Fanconi anemia group M protein</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>FA-M, MHF1, FAAP24-associated</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>250 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>2148 amino acids</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q8IWA5">Q8IWA5</a></td></tr>
<tr><td><strong>Cellular Location</strong></td><td>Nucleus (chromatin), cytoplasm</td></tr>
<tr><td><strong>Protein Class</strong></td><td>DNA translocase, SF2 helicase</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

FANCM (Fanconi Anemia Group M) is a 2148 amino acid DNA translocase that serves as a critical DNA damage sensor and remodelling enzyme in the Fanconi Anemia (FA) pathway. Unlike most FA proteins, FANCM itself does not require monoubiquitination for function — instead, it acts as an anchor that recruits the FA core complex to stalled replication forks and interstrand crosslinks (ICLs)[@collins2009]. Beyond its canonical role in ICL repair, FANCM has emerged as a key player in genome stability, R-loop resolution, mitochondrial function, and aging — areas with direct relevance to neurodegenerative diseases[@chen2015].

Protein Architecture

Domain Organization

FANCM contains multiple distinct domains that together enable its diverse functions:

| Domain | Position | Function |
|--------|----------|----------|
| DEAH-box helicase | N-terminal (aa 1–500) | ATP-dependent DNA translocase activity; remodels DNA structures |
| MM1 domain | Central (aa 500–900) | Binds DNA structure; contributes to substrate specificity |
| ERCC4 nuclease-like | C-terminal (aa 1700–2148) | Protein-protein interactions; FA core complex recruitment |
| FATC domain | C-terminal tip | Regulatory; coordinates with ATRX and BLM |

DNA Translocase Activity

FANCM belongs to the superfamily 2 (SF2) helicase family and functions as an ATP-dependent DNA translocase rather than a conventional helicase[@dey2022]. It uses the energy of ATP hydrolysis to:

• Remodel stalled replication forks: Moves the fork past ICLs without fully unwinding DNA
• Pivot DNA substrates: Can swing DNA arms and restructure replication intermediates
• Unwind short duplexes: Limited unwinding activity on short substrates
• Engage DNA:hybrid junctions: Specifically recognizes R-loops, Holiday junctions, and fork structures

Normal Function

Fanconi Anemia Pathway

FANCM is the entry point for the FA pathway at sites of DNA damage:

The FANCM-FAAP24 heterodimer recognizes damaged DNA through its DNA-binding domains, then uses ATP-dependent translocase activity to search for the ICL["@taniguchi2009"]. Once positioned, it recruits the FA core complex, which then monoubiquitinates the FANCD2-FANCI heterodimer. This ubiquitinated complex then orchestrates nucleolytic unhooking of the ICL and subsequent repair synthesis.

R-Loop Resolution

A critical and FA-independent function of FANCM is the resolution of R-loops (three-stranded structures consisting of an RNA:DNA hybrid and a displaced single DNA strand)[@hirata2020]. R-loops arise naturally during transcription but, when excessive, cause replication stress, DNA breaks, and genome instability. FANCM resolves pathological R-loops through:

Failure to resolve R-loops leads to transcription-replication conflicts, Chk1 activation, and cell death[@kelsky2023].

Mitochondrial Genome Maintenance

Emerging evidence shows FANCM participates in mitochondrial DNA (mtDNA) repair and maintenance[@kim2023]:

• FANCM localizes to mitochondria in neurons under DNA damage stress
• FANCM knockdown in neural cells causes mtDNA depletion and mitochondrial dysfunction
• FANCM deficiency leads to accumulation of mtDNA mutations with age
• The cGAS-STING innate immune pathway is activated by mitochondrial DNA released into the cytoplasm

Role in Neurodegeneration

FANCM Deficiency and Neurodegeneration

Mouse models of FANCM deficiency demonstrate a direct link between DNA repair defects and neurodegeneration[@chen2015]:

• Fancm-/- mice show progressive neurological decline starting at 6 months
• Accelerated aging: Reduced lifespan, premature graying, reduced body weight
• Neurodegenerative pathology: Progressive loss of Purkinje cells in the cerebellum, hippocampal neuronal dropout
• Behavioral deficits: Impaired motor coordination, spatial memory deficits
• Cellular hallmarks: Increased DNA damage markers (gamma-H2AX), replication stress, cellular senescence

Alzheimer'S Disease

Multiple studies link FANCM dysfunction to AD pathogenesis[@wang2020]:

• Promoter hypermethylation: FANCM promoter is hypermethylated in AD prefrontal cortex, correlating with reduced expression
• DNA damage accumulation: Increased gamma-H2AX and 53BP1 foci in AD neurons
• Replication stress: Stalled replication forks and fork collapse in vulnerable neuronal populations
• Therapeutic approach: Enhancing FANCM-mediated repair or compensatory pathways may reduce neurodegeneration[@liu2022]

Parkinson's Disease

FANCM variants and expression changes have been associated with PD risk[@xue2022]:

• Certain FANCM missense variants show modest association with PD risk
• FANCM expression is reduced in the substantia nigra of PD patients
• Mitochondrial dysfunction in PD (driven by PINK1/Parkin mutations) may be exacerbated by impaired FANCM repair
• The intersection of FANCM with mitophagy suggests overlapping pathways

Other Neurodegenerative Conditions

• Huntington's disease: CAG repeat expansion creates replication stress that may overwhelm FANCM-mediated repair
• Amyotrophic lateral sclerosis (ALS): TDP-43 pathology correlates with increased R-loops that FANCM would normally resolve
• Aging: Age-related decline in FANCM expression parallels accumulation of DNA damage in post-mitotic neurons

FANCM in Neuronal Development and Maintenance

Neural Stem Cells

FANCM is essential for the maintenance of neural stem/progenitor cells (NSPCs)[@l烟雾2021]:

• Self-renewal: Fancm-deficient NSPCs show reduced proliferative capacity in culture
• Differentiation: Skewing toward astrocyte differentiation at the expense of neurons
• Premature senescence: p21/p53 activation and SA-beta-gal positivity
• Epigenetic changes: Altered DNA methylation patterns suggesting accelerated aging

Post-Mitotic Neurons

Neurons are particularly vulnerable to DNA damage because they are post-mitotic and have high metabolic activity:

• Neuronal energy demands: High oxidative phosphorylation generates ROS that damage DNA
• Transcription-coupled repair deficiency: Neurons rely heavily on this pathway, which overlaps with FANCM functions
• Basal DNA damage: Neurons accumulate spontaneous DNA lesions throughout life
• Age-dependent decline: FANCM expression decreases with age, compounding the problem

cGAS-STING Activation

FANCM deficiency activates the innate immune cGAS-STING pathway through two mechanisms[@hirano2019]:

cGAS-STING activation drives:

• Type I interferon response genes (ISG15, MX1, OAS1)
• Chronic neuroinflammation
• Synaptic dysfunction
• Exacerbation of neurodegeneration

Therapeutic Potential

DNA Repair Enhancement

| Strategy | Approach | Stage | Reference |
|----------|---------|-------|-----------|
| Small molecule activators | Increase FANCM recruitment | Research | Liu 2022 |
| FA pathway modulators | Enhance FANCD2 monoubiquitination | Research | Chen 2021 |
| R-loop dissolvers | Reduce pathological R-loops | Preclinical | Hirata 2020 |
| cGAS-STING inhibitors | Block neuroinflammation | Preclinical | Hirano 2019 |

Targeting the FA Pathway in Neurodegeneration

Key therapeutic concepts:

• Increase FANCM expression: Histone deacetylase (HDAC) inhibitors may increase FANCM transcription
• Enhance recruitment: Pharmaceutical agents that stabilize the FANCM-FAAP24-DNA complex
• Reduce R-loop burden: Topoisomerase I inhibitors (caution needed), senataxin activators
• Mitochondrial protection: NAD+ precursors (NMN, NR) may reduce mtDNA damage burden

Interaction Network

FANCM interacts with a network of DNA repair and regulatory proteins:

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| FAAP24 | Obligate heterodimer | DNA damage recognition |
| MHF1/MHF2 | Heterotrimer complex | Enhanced chromatin binding |
| FANCD2 | Downstream of FANCM | Activated by FA core complex recruited by FANCM |
| BLM | Physical interaction | Joint resolution of recombination intermediates |
| ATR | Kinase signaling | Phosphorylates FANCM in response to replication stress |
| ATRX | Co-regulator | Chromatin remodeling at G4 structures |
| SLX4 | Scaffold recruitment | Nuclease complex assembly |
| DNA2 | Helicase/nuclease | Fork processing and restart |

Genetic Variants and Disease Risk

Pathogenic Variants

• FANCM nonsense variants cause classic Fanconi anemia (bone marrow failure, cancer predisposition)
• Hypomorphic variants with partial function may predispose to neurodegeneration without causing FA

Risk-Modifying Variants

• Certain FANCM polymorphisms show association with PD risk (OR ~1.3 for heterozygous carriers)
• Promoter variants affecting expression levels may modify disease progression

See Also

• [FANCM Gene](/genes/fancm) — Gene page for FANCM
• [Fanconi Anemia Pathway](/mechanisms/fanconi-anemia-pathway) — Overview of the FA pathway
• [FANCL](/proteins/fancl-protein) — E3 ubiquitin ligase in FA pathway
• [FANCD2](/proteins/fancd2-protein) — Key substrate of the FA pathway
• [DNA Repair Pathways and Neurodegeneration](/mechanisms/dna-repair-pathways-neurodegeneration)
• [R-loop Biology and Neurodegeneration](/mechanisms/r-loop-neurodegeneration)
• [Mitochondrial Dysfunction in AD/PD](/mechanisms/mitochondrial-dysfunction)

External Links

• [NCBI Protein: FANCM](https://www.ncbi.nlm.nih.gov/protein/NP_001123502)
• [UniProt: Q8IWA5](https://www.uniprot.org/uniprot/Q8IWA5)
• [Ensembl: ENSG00000187240](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000187240)
• [Fanconi Anemia Research Fund](https://www.fanconi.org/)
• [Allen Brain Atlas - FANCM Expression](https://human.brain-map.org/microarray/search/show?search_term=FANCM)

References